Picture of Jubilant Pharmova logo

JUBLPHARMA — Jubilant Pharmova News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Brief: Jubilant Pharmova Says USFDA Determines Inspection Classification Of 'Voluntary Action Indicated' For Roorkee Facility

April 17 (Reuters) - Jubilant Pharmova Ltd  JUBA.NS :
    * USFDA DETERMINES INSPECTION CLASSIFICATION OF 'VOLUNTARY
ACTION
INDICATED' FOR SOLID DOSAGE MANUFACTURING FACILITY AT ROORKEE
    * FACILITY IS CONSIDERED TO BE IN ACCEPTABLE STATE OF
COMPLIANCE
WITH REGARD TO CURRENT GOOD MANUFACTURING PRACTICES

Source text for Eikon:  ID:nBSE4MK70w 
Further company coverage:  JUBA.NS 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Jubilant Pharmova

See all news